Elevated SREBP-1c levels found in patients with HCC tumors correlated with poor survival [56], and the SREBP-1c inhibitor betulin has been shown to have anti-tumor effects in HCC [56]. This evidence concerns the gene SREBF1 and hepatocellular carcinoma.